Cero Therapeutics Holdings CERO
OTC CERO
$0.00 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cero Therapeutics Holdings, Inc. (CERO) Non-Current Deffered Revenue (2021 - 2023)

Updated

Cero Therapeutics Holdings' Non-Current Deffered Revenue was $9.15 million in Q4 2023, unchanged from $9.15 million a year earlier and unchanged from the prior quarter.

Analysis

Cero Therapeutics Holdings, Inc. (CERO) Non-Current Deffered Revenue (2021 - 2023) Analysis & Trends

From Q4 2021 onward, Cero Therapeutics Holdings has reported Non-Current Deffered Revenue for 9 quarters.

  • In earlier years, Non-Current Deffered Revenue was $9.15 million in FY2022 (unchanged) and $9.15 million in FY2021.
  • Per Business Quant data, CERO's Non-Current Deffered Revenue in the three quarters before Q4 2023 was $9.15 million (Q3 2023), $9.15 million (Q2 2023) and $9.15 million (Q1 2023).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 9.15 Mn
Sep 30, 2023 9.15 Mn
Jun 30, 2023 9.15 Mn
Mar 31, 2023 9.15 Mn
Dec 31, 2022 9.15 Mn
Sep 30, 2022 9.15 Mn
Jun 30, 2022 9.15 Mn
Mar 31, 2022 9.15 Mn
Dec 31, 2021 9.15 Mn
API Access

Cero Therapeutics Holdings, Inc. Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CERO&period=max&api_key=YOUR_API_KEY